Private Advisor Group’s Recursion Pharmaceuticals RXRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $399K | Buy |
78,931
+34,624
| +78% | +$175K | ﹤0.01% | 1810 |
|
|
2025
Q1 | $234K | Buy |
44,307
+12,880
| +41% | +$68.1K | ﹤0.01% | 2011 |
|
|
2024
Q4 | $212K | Buy |
31,427
+16,008
| +104% | +$108K | ﹤0.01% | 2057 |
|
|
2024
Q3 | $102K | Buy |
15,419
+3,432
| +29% | +$22.6K | ﹤0.01% | 2308 |
|
|
2024
Q2 | $89.9K | Buy |
+11,987
| New | +$89.9K | ﹤0.01% | 2240 |
|
|
2023
Q4 | – | Sell |
-10,326
| Closed | -$79K | – | 2265 |
|
|
2023
Q3 | $79K | Buy |
+10,326
| New | +$79K | ﹤0.01% | 1956 |
|